These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 16974186)

  • 1. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A; Pani A
    J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F; Hebrani P; Rezaei Ardani A; Rafee E
    Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S
    Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
    Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
    Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular aripiprazole in the control of agitation.
    Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility.
    Citrome L; Shope CB; Nolan KA; Czobor P; Volavka J
    Int Clin Psychopharmacol; 2007 Nov; 22(6):356-62. PubMed ID: 17917554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W
    J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
    Kushner SF; Khan A; Lane R; Olson WH
    Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.
    San L; Arranz B; Querejeta I; Barrio S; De la Gándara J; Pérez V
    Eur Psychiatry; 2006 Dec; 21(8):539-43. PubMed ID: 16697151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
    Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L
    Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
    Chengappa KN; Gershon S; Levine J
    Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay.
    Johnson JM; Wu CY; Winder GS; Casher MI; Marshall VD; Bostwick JR
    J Dual Diagn; 2016; 12(3-4):244-251. PubMed ID: 27710762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial.
    Afshar H; Roohafza H; Mousavi G; Golchin S; Toghianifar N; Sadeghi M; Talaei M
    J Psychopharmacol; 2009 Mar; 23(2):157-62. PubMed ID: 18515465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.